Canada vs Singapore: Proportion of isolates with decreased susceptibility or resistance
Canada
1.4
in 2020
Singapore
2.2
in 2020
Canada rank
7th
Singapore rank
6th
Proportion of isolates with decreased susceptibility or resistance over time
- Canada
- Singapore
How they compare
Singapore currently reports 2.2 against 1.4 in Canada, a difference of 0.8.
That makes Singapore's figure about 1.6 times Canada's.
The two have swapped places 3 times across 11 shared years of data; in 2009 it was Canada ahead.
Canada ranks 7th and Singapore ranks 6th of 52 countries.
Across the 3 decades both report, Canada averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | Canada | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.09 | 1.25 | 1.84 | Canada |
| 2010s | 3.56 | 2.43 | 1.13 | Canada |
| 2020s | 1.4 | 2.2 | 0.8 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Canada or Singapore?
- Singapore, at 2.2 against 1.4 in Canada as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Canada and Singapore?
- 0.8, with Singapore ahead.
- How many years of comparable data are there for Canada and Singapore?
- 11 years are reported by both, from 2009 to 2020.
- How do Canada and Singapore rank globally for proportion of isolates with decreased susceptibility or resistance?
- Canada ranks 7th and Singapore ranks 6th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.